The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ibuprofen Bril 400 mg film-coated tablet



Brillpharma (Ireland) LimitedPA22749/022/002

Main Information

Trade NameIbuprofen Bril 400 mg film-coated tablet
Active SubstancesIbuprofen
Dosage FormFilm-coated tablet
Licence HolderBrillpharma (Ireland) Limited
Licence NumberPA22749/022/002

Group Information

ATC CodeM01AE Propionic acid derivatives
M01AE01 ibuprofen

Status

License statusAuthorised
Licence Issued25/01/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back